Medtronic receives ce mark for extravascular defibrillator system that treats abnormal heart rhythms

Ev-icd defibrillation lead placed outside of heart and veins, preserving vasculature dublin , feb. 17, 2023 /prnewswire/ -- medtronic plc (nyse:mdt) has received ce (conformitÉ europÉenne) mark for the aurora ev-icd™ mri surescan™ (extravascular implantable cardioverter-defibrillator) and epsila ev™ mri surescan™ defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest. the aurora ev-icd system provides the life-saving benefits of traditional icds while avoiding certain risks because its lead (thin wire) is placed outside the heart and veins.
MDT Ratings Summary
MDT Quant Ranking